Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Navidea Biopharmaceuticals, Inc. Common Stock (NY: NAVB )

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, Oct 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.0766 (4)
Ask (Size) 0.0780 (9)
Prev. Close 0.0779
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 100,084,385
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
From Navidea Biopharmaceuticals, Inc.
Via Business Wire

Performance

More News

Read More
Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
Why Is SOFI Stock Up 19% Today?
Via InvestorPlace
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Via Benzinga
Why Navidea Biopharmaceuticals Shares Are Nosediving
Via Benzinga
Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
Via InvestorPlace
Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer
From Navidea Biopharmaceuticals, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.